Cargando…

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic

Remdesivir (GS-5734), a drug initially developed to treat hepatitis C and Ebola virus disease, was the first approved treatment for severe coronavirus disease 2019 (COVID-19). However, apart from remdesivir, there is a paucity of other specific anti-viral agents against SARS-CoV-2 infection. In 2017...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallianou, Natalia G., Tsilingiris, Dimitrios, Christodoulatos, Gerasimos Socrates, Karampela, Ιrene, Dalamaga, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles from the Vaccines, Immune Response, Therapeutic interventions and COVID-19 Special Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143911/ https://www.ncbi.nlm.nih.gov/pubmed/34056571 http://dx.doi.org/10.1016/j.metop.2021.100096

Ejemplares similares

Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
por: Amanatidou, Evropi, et al.
Publicado: (2022)

The effect of COVID-19 pandemic on the attendance and clinical outcomes of patients with ophthalmic disease: A mini-review
por: Syriga, Maria, et al.
Publicado: (2021)

Perspectives in vaccines, immune response, therapeutic interventions and COVID-19
por: Karampela, Irene
Publicado: (2022)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
por: Vallianou, Natalia G., et al.
Publicado: (2023)

Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2023)

Saffron for “toning down” COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2021)

Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients
por: Karampela, Irene, et al.
Publicado: (2023)

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
por: Dalamaga, Maria, et al.
Publicado: (2021)

Mycobiome and Cancer: What Is the Evidence?
por: Vallianou, Natalia, et al.
Publicado: (2021)

Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study
por: Karampela, Irene, et al.
Publicado: (2022)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

COVID-19 vaccines: Current evidence and considerations
por: Tavilani, Alireza, et al.
Publicado: (2021)

Serious complications of COVID-19 vaccines: A mini-review
por: Fragkou, Paraskevi C., et al.
Publicado: (2021)

Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine
por: Abbasi, Ebrahim, et al.
Publicado: (2021)

Herbal medicine use for the management of COVID-19: A review article
por: Demeke, Chilot Abiyu, et al.
Publicado: (2021)

A systematic review on the effects of Echinacea supplementation on cytokine levels: Is there a role in COVID-19?
por: Aucoin, Monique, et al.
Publicado: (2021)

Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature
por: Siolos, Athanasios, et al.
Publicado: (2021)

Roles of existing drug and drug targets for COVID-19 management
por: Ayele, Akeberegn Gorems, et al.
Publicado: (2021)

Major cardiac concerns in therapy and vaccinations for COVID-19
por: Junapudi, Syam Sundar, et al.
Publicado: (2021)

Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
por: Kifle, Zemene Demelash
Publicado: (2021)

The impact of dawn to sunset fasting on immune system and its clinical significance in COVID-19 pandemic
por: Bhatti, Sundus I., et al.
Publicado: (2021)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study
por: Christodoulatos, Gerasimos Socrates, et al.
Publicado: (2021)

Life in 90 words: opportunities for person-centred care amidst COVID-19
por: Theodoros, Theo, et al.
Publicado: (2020)

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Prediabetes screening: Questionable benefits in the golden years
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

To tele- or not to telehealth? Ongoing COVID-19 challenges for private psychiatry in Australia
por: Looi, Jeffrey CL, et al.
Publicado: (2020)

Of mice and men: Considerations on adipose tissue physiology in animal models of obesity and human studies()
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

The ongoing value of first few X studies for COVID-19 in the Western Pacific Region
por: Marcato, Adrian J, et al.
Publicado: (2022)

Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsis
por: Karampela, Irene, et al.
Publicado: (2021)

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
por: Kuzu Kumcu, Müge, et al.
Publicado: (2022)

Stress and Eating Behaviors of Dietitians Amidst the COVID-19 Pandemic
por: Floberg, Josh, et al.
Publicado: (2022)

Affirmative action in healthcare resource allocation: Vaccines, ventilators and race
por: Zohny, Hazem, et al.
Publicado: (2022)

Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
por: Chakhtoura, M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1so58amb93aoslo2lfi5t8fmfu